{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/274333215"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Pre- and post-treatment EOLPRO scores were hypothesised to moderately, rather than substantially, agree because outcome measurements were taken five days apart and changes in other deteriorating symptoms such as fatigue, or treatment side effects, could affect the ability to manage affairs at the end of life in this subgroup of participants with stable pain [54], reducing test-retest agreement." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "pubmedcentralcanada.ca" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/428917439"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/274333215"] } } }
